Google

00150001_00175000/167301 Index


    167301 1394-00-9 5337 R.P. 78355-64-3 8025-81-8 Antibiotic 799 DRG-
    0061 EINECS 232-429-6 Espiramicin Espiramicina Espiramicina
    [INN-Spanish] Foromacidin HSDB 7027 IL 5902 NSC-64393 Provam
    ycin RP 5337 Rovamycin SPIRAMYCIN Sequamycin Spiramycin [USA
    N:BAN:INN] Spiramycine [INN-French] Spiramycinum [INN-Latin]


    Smiles: [Xx]OC1CC(=O)OC(C)CC=CC=CC(OC2CCC(N(C)C)C(C)O2)C(C)CC(CC=O)C
    (OC3OC(C)C(OC4OC(C)C(O)C(O)(C)C4)C(N(C)C)C3O)C1OC

    pdb file: 167301.pdb
    sdf file: 167301.sdf

    Please note: images may show incorrect connectivity due to improper geometry. We will be working to improve this situation. For now, the left image should be correct, and the other two are correct, if they match the first.


    Image Links


    Molecule Name Links

    More coming soon!

    Back to top


    RSS News Feed

    Add
    Subscribe
    Add
    (syndicate freely:)


    PubChem Fields

      pubchem total charge
      0
      pubchem substance id
      167301
      pubchem substance version
      3
      pubchem ext datasource name
      ChemIDplus
      pubchem ext datasource regid
      008025818
      pubchem substance synonym
      1394-00-9 5337 R.P. 78355-64-3 8025-81-8 Antibiotic 799 DRG-0061 EINECS 232-429-6 Espiramicin Espiramicina Espiramicina [INN-Spanish] Foromacidin HSDB 7027 IL 5902 NSC-64393 Provamycin RP 5337 Rovamycin SPIRAMYCIN Sequamycin Spiramycin [USAN:BAN:INN] Spiramycine [INN-French] Spiramycinum [INN-Latin]
      pubchem generic registry name
      1394-00-9 78355-64-3 8025-81-8
      pubchem xref ext id
      008025818
      pubchem ext datasource url
      http://chem.sis.nlm.nih.gov/chemidplus/
      pubchem ext substance url
      http://chem.sis.nlm.nih.gov/chemidplus/direct.jsp?result=advanced&regno=008025818
      pubchem bondannotations
      32 10 6 40 11 6 19 16 5 46 17 6 18 61 6 22 62 6 23 31 5 24 33 6 28 38 6 20 3 6 30 37 6 39 51 6 25 4 6 41 63 6 43 53 6 54 60 6 21 6 6 24 7 5 27 8 5 29 9 6


    Other Related Links

    More coming soon!


    :-) --- John Holmes